The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia

卷:12

Review

关键词: PPAR-GAMMA LIGANDS;    POTENTIAL THERAPEUTIC TARGET;    HUMAN CHORIONIC-GONADOTROPIN;    DIFFERENTIAL EXPRESSION;    PLACENTAL DEVELOPMENT;    DIABETES-MELLITUS;    BLOOD-PRESSURE;    ALPHA LIGAND;    KAPPA-B;    TROPHOBLAST;   

DOI  :  10.3390/cells12040647

来源: SCIE

【 摘 要 】

Preeclampsia is a common pregnancy-related hypertensive disorder. Often presenting as preexisting or new-onset hypertension complicated by proteinuria and/or end-organ dysfunction, preeclampsia significantly correlates with maternal and perinatal morbidity and mortality. Peroxisome proliferator-activated receptors (PPARs) are nuclear receptor proteins that regulate gene expression. In order to investigate the role of PPARs in the pathophysiology of preeclampsia, we conducted a literature review using the MEDLINE and LIVIVO databases. The search terms peroxisome proliferator-activated receptor, PPAR, and preeclampsia were employed and we were able to identify 35 relevant studies published between 2002 and 2022. Different study groups reached contradictory conclusions in terms of PPAR expression in preeclamptic placentae. Interestingly, PPAR gamma agonists alone, or in combination with well-established pharmaceutical agents, were determined to represent novel, potent anti-preeclamptic treatment alternatives. In conclusion, PPARs seem to play a significant role in preeclampsia.